Wells Fargo Starts XenoPort (XNPT) at Outperform; Multiple Catalysts for Near-Term Appreciation
Tweet Send to a FriendGet Alerts XNPT Hot Sheet
Price: $5.78 +7.24%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade XNPT Now!
Wells Fargo initiates coverage on XenoPort (NASDAQ: XNPT) with an Outperform. PT range $7-9.
Analyst, Brian Abrahams, said, "We are most enthusiastic about the prospects of XP23829, XNPT's prodrug of the active ingredient in BIIB's BG-12, and expect
increasing enthusiasm over the drug's long-term prospects to drive share upside. While the opportunity for marketed agent Horizant and phase III candidate arbaclofen placarbil (AP) may be more modest, we believe their combined future revenue streams put a floor in valuation near where the shares currently trade."
For an analyst ratings summary and ratings history on XenoPort click here. For more ratings news on XenoPort click here.
Shares of XenoPort closed at $5.17 yesterday, with a 52 week range of $3.46-$7.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Brian Abrahams, said, "We are most enthusiastic about the prospects of XP23829, XNPT's prodrug of the active ingredient in BIIB's BG-12, and expect
increasing enthusiasm over the drug's long-term prospects to drive share upside. While the opportunity for marketed agent Horizant and phase III candidate arbaclofen placarbil (AP) may be more modest, we believe their combined future revenue streams put a floor in valuation near where the shares currently trade."
For an analyst ratings summary and ratings history on XenoPort click here. For more ratings news on XenoPort click here.
Shares of XenoPort closed at $5.17 yesterday, with a 52 week range of $3.46-$7.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Ascendiant Capital Starts Polypore International (PPO) at Neutral
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells Fargo
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
